Submission of Annual Report for Financial Year 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Limited has submitted its 33rd Annual Report for FY 2024-25 to BSE along with the notice for its 33rd Annual General Meeting scheduled for Monday, 29th September 2025 at 4:00 PM, to be held via video conferencing. The AGM agenda includes ordinary business of adopting the audited financial statements and re-appointing Managing Director Vishwambar Kameshwar Singh, who retires by rotation. Special business items include regularizing the appointment of Deepak Ashokkumar Rochani as Independent Director for five years (till June 26, 2030), approving enhanced borrowing limits of up to Rs. 100 crore under Section 180(1)(c), authorising disposal/creation of charge on company assets up to Rs. 100 crore, and approving loans, guarantees and investments up to Rs. 100 crore under Sections 186 and 185. The company's registered office is in Ahmedabad, Gujarat, and it is listed on BSE with code 524590.
For shareholders, this is primarily a compliance filing with no immediate price action expected, but the AGM will feature key votes on significantly higher borrowing and investment limits of Rs. 100 crore each, which could indicate plans for future expansion or acquisitions. The re-appointment of the Managing Director and addition of a new independent director with capital markets expertise also signals governance continuity.